Research Papers

25 of 325 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression.
Cui X; Cui Y; Du T; Jiang X; Song C; Zhang S; Ma C; Liu Y; Ni Q; Gao Y; Wang G.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Therapeutic Effects of Milk Thistle (<i>Silybum marianum</i> L.) and Artichoke (<i>Cynara scolymus</i> L.) on Nonalcoho…
Doostkam A; Fathalipour M; Anbardar MH; Purkhosrow A; Mirkhani H.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Usefulness of Macroscopic On-Site Evaluation Using a Stereomicroscope during EUS-FNB for Diagnosing Solid Pancreatic Le…
Ishikawa T; Ohno E; Mizutani Y; Iida T; Uetsuki K; Yashika J; Yamada K; Gibo N; Aoki T; Kataoka K; Mori H; Takada Y; Takahashi H; Aoi H; Kato K; Yamamura T; Kakushima N; Furukawa K; Nakamura M; Hirooka Y; Kawashima H.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma.
Feng Y; Tang X; Li C; Su Y; Wang X; Li N; Zhang A; Jiang F; Wu C.
Can J Gastroenterol Hepatol (Unknown)
Published: 2022
2/6 Transparent
Prognostic Analysis of Different Metastatic Patterns in Invasive Intraductal Papillary Mucinous Neoplasm: A Surveillanc…
Zhou C; Liu Z; Zhou Y; Ren D; Liu K; Qin G; Zhang H; Liang X; Gou S; Wu H.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
1/6 Transparent
Treatment Effect of a Vascular-Disrupting Agent Dynamically Monitored by DWI: An Animal Experimental Study.
Huang D; Yang R; Zou Y; Lin H; Xu X; Wei X; Chang H; Wu L; Ding W; Tang W; Jiang X.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC.
Wei Y; Song Q; Zhang F; Yuan T.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
1/6 Transparent
The Regularity of the Site of Impaction in Recurrent Gallstone Ileus: A Systematic Review and Meta-Analysis of Reported…
Alzerwi NAN; Idrees B; Alsareii S; Aldebasi Y; Alsultan A.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
1/6 Transparent
The Use of Machine Learning to Create a Risk Score to Predict Survival in Patients with Hepatocellular Carcinoma: A TCG…
Tohme S; Yazdani HO; Rahman A; Handu S; Khan S; Wilson T; Geller DA; Simmons RL; Molinari M; Kaltenmeier C.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Chronic Liver Disease in Ethiopia with a Particular Focus on the Etiological Spectrums: A Systematic Review and Meta-An…
Tesfaye BT; Feyissa TM; Workneh AB; Gudina EK; Yizengaw MA.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
3/6 Transparent
Registered
Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease.
Wetwittayakhlang P; Albader F; Golovics PA; Hahn GD; Bessissow T; Bitton A; Afif W; Wild G; Lakatos PL.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Adenocarcinoma with Mixed Subtypes in the Early and Advanced Gastric Cancer.
Zhao X; Li Y; Yang Z; Zhang H; Wang H; Lin J; Liu J; Zhao Q.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Optimal Timing of Simethicone Supplement for Bowel Preparation: A Prospective Randomized Controlled Trial.
Wu ZW; Zhan SG; Yang MF; Meng YT; Xiong F; Wei C; Li YX; Zhang DG; Xu ZL; Wu BH; Shi RY; Yao J; Wang LS; Li DF.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Nomogram to Predict the Survival of Chinese Patients with Alcohol-Related Liver Disease.
Duan F; Liu C; Liu Y; Chang C; Zhai H; Xing H; Cheng J; Yang S.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Comparison of General and Liver-Specific Prognostic Scores in Their Ability to Predict Mortality in Cirrhotic Patients …
Costa E Silva PP; Codes L; Rios FF; Esteve CP; Valverde Filho MT; Lima DOC; de Almeida Filho GF; Morais MCA; Lima BC; Chagas PBO; Boa-Sorte N; Bittencourt PL.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
3/6 Transparent
Registered
Long-Term Impact of Hepatitis C Virus Eradication on Liver Stiffness in Egyptian Patients.
Zakareya T; Elhelbawy M; Elzohry H; Eltabbakh M; Deif M; Abbasy M.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
1/6 Transparent
LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma.
Luo Y; Lin J; Zhang J; Song Z; Zheng D; Chen F; Zhuang X; Li A; Liu X.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
3/6 Transparent
Data Funding Declared
Whole Exome Sequencing Identifies Two Novel Mutations in a Patient with UC Associated with PSC and SSA.
Wu D; Chen D; Shi W; Liu W; Zhou W; Qian J.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined …
Li Z; Chen Q; Zhang W; Si G; Li J; Jiao D; Han X.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
LncRNA ELF3-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Chen T; Zhu C; Wang X; Pan Y.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Health-Related Quality of Life and Its Influencing Factors in Patients with Hepatitis B: A Cross-Sectional Assessment i…
Chen P; Zhang F; Shen Y; Cai Y; Jin C; Li Y; Tu M; Zhang W; Wang Y; Zhang SF; Wang J; Li L.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Feasibility and Safety of Mark-Guided Submucosal Tunneling Endoscopic Resection for Treatment of Esophageal Submucosal …
Wu BH; Shi RY; Zhang HY; Liu TT; Tian YH; Xiong F; Xu ZL; Zhang DG; Li DF; Yao J; Wang LS.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Conjugated Hyperbilirubinemia in Infants: Is There Still a Role for ERCP?
Stovicek J; Hlava S; Keil R; Drabek J; Lochmannova J; Koptová P; Wasserbauer M; Frybova B; Snajdauf J; Kotalova R; Rygl M.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
2/6 Transparent
Eliciting and Understanding Primary Care and Specialist Mental Models of Cirrhosis Care: A Cognitive Task Analysis Stud…
Barber T; Toon L; Tandon P; Green LA.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway.
Guo M; Li N; Zheng J; Wang W; Wu Y; Han X; Guo J; Chen W; Bai Z; Bai W; Wu J.
Can J Gastroenterol Hepatol (Unknown)
Published: 2021
3/6 Transparent
Funding Declared